510(k) device
ELITA Femtosecond Laser System, ELITA Patient Interface
Johnson & Johnson Surgical Vision, Inc. · Ophthalmic Femtosecond Laser (OOE, Class II) · First FDA decision Apr 14, 2023, newest Apr 14, 2023Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "ELITA"
MAUDE reports
40
Brand "ELITA", since 2015
PubMed studies
49
Mentioning "ELITA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ELITA Femtosecond Laser System, ELITA Patient Interface
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K223566 · Decided Apr 14, 2023 · 136 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ELITA", any status and sponsor, newest update first.
CB ConsultingNot on our public-company list
NCT07926425 · 175 participants (planned) · Start Nov 4, 2026 · Primary completion Jan 31, 2027
Device: Femtosecond LASER · For: Visual Acuity
Sites: Rancho Cucamonga, California
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ELITA", and for the whole product code for context.
This brand
40 reports: 21 malfunction, 19 injury, 0 death
Whole product code OOE
4,559 reports: 2,002 malfunction, 2,527 injury, 0 death
Newest reports for this brand
- ELITAMalfunction
3012236936-2026-000281 · Received Sep 28, 2026 · Event dated Aug 31, 2026
Device type: Ophthalmic Femtosecond Laser (OOE)
Device problem as coded: Computer Software Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ELITA"[tiab]. The summary above synthesizes these.
- Characterization of Disrupted Tissue Interface Thickness for Keratorefractive Lenticule Extraction Procedure With ELITA Femtosecond Laser.
Minoguchi H, Umar A, Fu H · Transl Vis Sci Technol · 2024Research Support, Non-U.S. Gov't
- Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi PA, Viganò R, Conti S, et al. · Transpl Int · 2023
- Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant Association.
Hessheimer AJ, Hartog H, Marcon F, et al. · J Hepatol · 2025Systematic Review, Practice Guideline
- Proceedings of the 28th Annual Congress of the International Liver Transplantation Society.
Shaji Mathew J, Shingina A, Khan MQ, et al. · Liver Transpl · 2024Conference Proceedings, Research Support, N.I.H., Extramural
- Update on pediatric liver transplantation in Europe 2022: An ELITA-ESPGHAN report.
Junge N, Karam V, Hartog H, et al. · J Pediatr Gastroenterol Nutr · 2025Research Support, Non-U.S. Gov't
- Atomic Force Microscopy and Scanning Electron Microscopy for Characterization of Interface Surface Roughness After ELITA Femtosecond Laser Treatments.
Minoguchi H, Teus MA, Fu H · Transl Vis Sci Technol · 2025
- Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens.
Kunstmann S, Scheidt T, Buchwald S, et al. · Viruses · 2018Research Support, Non-U.S. Gov't
- Liver transplantation and vascular tumours.
Bonaccorsi-Riani E, Lerut JP · Transpl Int · 2010
- Vascular tumours of the liver: a particular story.
Lerut J, Iesari S · Transl Gastroenterol Hepatol · 2018Review
- Bacteriophage tailspike protein based assay to monitor phase variable glucosylations in Salmonella O-antigens.
Schmidt A, Rabsch W, Broeker NK, et al. · BMC Microbiol · 2016
- Erratum: Safety and Effectiveness of Smooth Incision Lenticular Keratomileusis (SILKTM) Using the ELITA(TM) Femtosecond Laser System for Correction of Myopic and Astigmatic Refractive Errors [Corrigendum].
Clin Ophthalmol · 2024Published Erratum
- THE 2017 JOINT INTERNATIONAL CONGRESS OF ILTS, ELITA & LICAGE.
Transplantation · 2017
Other devices of this type
Also filed under product code OOE.
- LENSAR Laser System - fs 3D (LLS-fs 3D)Lensar, Inc. · 510(k) 2018
- VICTUS Femtosecond Laser PlatformTechnolas Perfect Vision GmbH · 510(k) 2020
- LenSx Laser System (8065000944)Alcon Laboratories, Inc. · 510(k) 2025
- Catalys Precision Laser SystemAmo Manufacturing USA, LLC · 510(k) 2023
- Catalys Precision Laser SystemOptimedica Corporation · 510(k) 2016
- TbdLensar, Inc. · 510(k) 2013
- Lensx 550 Laser System. Model 550Lensx Lasers, Inc. · 510(k) 2010
- FEMTO LDV Z8 Femtosecond Surgical LaserSie Ag,Surgical Instrument Engineering · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.